Crossmark

Nanovesicular-Mediated Intranasal Drug Therapy for Neurodegenerative Disease

Crossref DOI link: https://doi.org/10.1208/s12249-023-02625-5

Published Online: 2023-09-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Singh, Shalu

Shukla, Rahul https://orcid.org/0000-0002-4864-0133
License Information

Text and Data Mining valid from 2023-09-02

Version of Record valid from 2023-09-02
More Information

Article History

Received: 26 April 2023

Accepted: 25 July 2023

First Online: 2 September 2023

Declarations

:

: The authors declare no competing interests.